This study found that Amphotericin B vaginal suppositories are a viable treatment option for refractory vaginitis caused by non- albicans Candida -“Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories” (Am J Obstet Gynecol. 2005 Jun;192(6):2009-12).
OBJECTIVE: This study was undertaken to investigate whether amphotericin B vaginal suppositories would be effective in the treatment of non- albicans Candida vaginitis in women who failed conventional therapy.
STUDY DESIGN: Thirty-two patients were identified with non- albicans Candida vaginitis. These patients were treated with conventional antifungal agents. Ten patients had persistence of the non- albicans Candida infection after treatment. Amphotericin B 50-mg vaginal suppositories were given nightly for 14 days to this subgroup of treatment failures.
RESULTS: Of 10 women, 8 (80%) who were treated with amphotericin B vaginally initially showed no further infection. One of the treatment successes had 2 recurrences and responded to a second course of amphotericin B but failed a third course. If this patient is considered a treatment failure, then amphotericin B vaginal suppositories were successful in 70% of patients. The medication was well tolerated and local side effects were minimal.
CONCLUSION: Amphotericin B vaginal suppositories are a viable treatment option for refractory vaginitis caused by non- albicans Candida . PMID:15970877
We have the ability to compound amphotericin B into a vaginal suppository.
Copyright AgeVtal Pharmacy.